1,984
Views
21
CrossRef citations to date
0
Altmetric
Articles

Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women

, , , , , , , , & show all
Pages 197-210 | Received 06 Sep 2018, Accepted 17 Dec 2018, Published online: 21 Jan 2019

References

  • Ralph LJ, McCoy SI, Shiu K, et al. Does hormonal contraceptive use increase women’s risk of HIV acquisition? A meta-analysis of observational studies. Lancet Infect Dis. 2015;15:181–189. doi:10.1016/S1473-3099(14)71052-7.
  • Morrison CS, Chen P-L, Kwok C, et al. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS Med. 2015;12:e1001778. doi:10.1371/journal.pmed.1001778.
  • Polis CB, Curtis KM, Hannaford PC, et al. An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women. AIDS. 2016;30:2665–2683. doi:10.1097/QAD.0000000000001228.
  • Hapgood JP, Kaushic C, Hel Z. Hormonal contraception and HIV-1 acquisition: biological mechanisms. Endocr Rev. 2018;39:36–78. doi:10.1210/er.2017-00103.
  • Birse KD, Romas LM, Guthrie BL, et al. Genital injury signatures and microbiome alterations associated with depot medroxyprogesterone acetate usage and intravaginal drying practices. J Infect Dis. 2017;215:590–598.
  • Quispe Calla NE, Vicetti Miguel RD, Boyaka PN, et al. Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection. Mucosal Immunol. 2016;9:1571–1583. doi:10.1038/mi.2016.22.
  • Tasker C, Davidow A, Roche NE, et al. Depot medroxyprogesterone acetate administration alters immune markers for HIV preference and increases susceptibility of peripheral CD4(+) T cells to HIV infection. Immunohorizons. 2017;1:223–235. doi:10.4049/immunohorizons.1700047.
  • Michel KG, Huijbregts RPH, Gleason JL, et al. Effect of hormonal contraception on the function of plasmacytoid dendritic cells and distribution of immune cell populations in the female reproductive tract. J Acquir Immune Defic Syndr. 2015;68:511–518. doi:10.1097/QAI.0000000000000531.
  • Roxby AC, Fredricks DN, Odem-Davis K, et al. Changes in vaginal microbiota and immune mediators in HIV-1-seronegative Kenyan women initiating depot medroxyprogesterone acetate. J Acquir Immune Defic Syndr. 2016;71:359–366. doi:10.1097/QAI.0000000000000866.
  • Ma B, Forney LJ, Ravel J. Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol. 2012;66:371–389. doi:10.1146/annurev-micro-092611-150157.
  • Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA. 2011;108(Suppl 1):4680–4687. doi:10.1073/pnas.1002611107.
  • Brotman RM. Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J Clin Invest. 2011;121:4610–4617. doi:10.1172/JCI57172.
  • Ravel J, Gajer P, Abdo Z, et al. Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology. 2014;160:2272–2282. doi:10.1099/mic.0.081034-0.
  • O’Hanlon DE, Moench TR, Cone RA. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect Dis. 2011;11:200. doi:10.1186/1471-2334-11-200.
  • Breshears LM, Edwards VL, Ravel J, et al. Lactobacillus crispatus inhibits growth of Gardnerella vaginalis and Neisseria gonorrhoeae on a porcine vaginal mucosa model. BMC Microbiol. 2015;15:276. doi:10.1186/s12866-015-0608-0.
  • Majhenič AČ, Venema K, Allison GE, et al. DNA analysis of the genes encoding acidocin LF221 A and acidocin LF221 B, two bacteriocins produced by Lactobacillus gasseri LF221. Appl Microbiol Biotechnol. 2004;63:705–714. doi:10.1007/s00253-003-1424-2.
  • Maldonado-Barragán A, Caballero-Guerrero B, Martín V, et al. Purification and genetic characterization of gassericin E, a novel co-culture inducible bacteriocin from Lactobacillus gasseri EV1461 isolated from the vagina of a healthy woman. BMC Microbiol. 2016;16:37. doi:10.1186/s12866-016-0663-1.
  • Redondo-Lopez V, Cook RL, Sobel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis. 1990;12:856–872. doi:10.1093/clinids/12.5.856.
  • Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis. 1999;180:1863–1868. doi:10.1086/315127.
  • Kyongo JK, Crucitti T, Menten J, et al. Cross-sectional analysis of selected genital tract immunological markers and molecular vaginal microbiota in Sub-Saharan African women, with relevance to HIV risk and prevention. Clin Vaccine Immunol. 2015;22:526–538. doi:10.1128/CVI.00762-14.
  • Atashili J, Poole C, Ndumbe PM, et al. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008;22:1493–1501. doi:10.1097/QAD.0b013e3283021a37.
  • Myer L, Denny L, Telerant R, et al. Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. J Infect Dis. 2005;192:1372–1380. doi:10.1086/462427.
  • Taha TE, Hoover DR, Dallabetta GA, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 1998;12:1699–1706. doi:10.1097/00002030-199813000-00019.
  • Miller L, Patton DL, Meier A, et al. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol. 2000;96:431–439.
  • Mitchell CM, McLemore L, Westerberg K, et al. Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells. J Infect Dis. 2014;210:651–655. doi:10.1093/infdis/jiu176.
  • Achilles SL, Austin MN, Meyn LA, et al. Impact of contraceptive initiation on vaginal microbiota. Am J Obstet Gynecol. 2018;218:622 e621–622 e610. doi:10.1016/j.ajog.2018.02.017.
  • Brooks JP, Edwards DJ, Blithe DL, et al. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. Contraception. 2017;95:405–413. doi:10.1016/j.contraception.2016.11.006.
  • Birse KD, Romas LM, Guthrie BL, et al. Genital injury signatures and microbiome alterations associated with depot medroxyprogesterone acetate usage and intravaginal drying practices. J Infect Dis. 2017;215:590–598.
  • Borgdorff H, Verwijs MC, Wit FWNM, et al. The impact of hormonal contraception and pregnancy on sexually transmitted infections and on cervicovaginal microbiota in African sex workers. Sex Transm Dis. 2015;42:143–152. doi:10.1097/OLQ.0000000000000245.
  • Nossa CW. Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome. World J Gastroenterol. 2010;16:4135–4144. doi:10.3748/wjg.v16.i33.4135.
  • Nossa CW, Tang YW, Pei Z. Pearls and pitfalls of genomics-based microbiome analysis. Emerg Microbes Infect. 2012;1:e45. doi:10.1038/emi.2012.41.
  • Pei AY, Oberdorf WE, Nossa CW, et al. Diversity of 16S rRNA genes within individual prokaryotic genomes. Appl Environ Microbiol. 2010;76:3886–3897. doi:10.1128/AEM.02953-09.
  • Mishell DR. Pharmacokinetics of depot medroxyprogesterone acetate contraception. J Reprod Med. 1996;41:381–390.
  • Jeppsson S, Gershagen S, Johansson EDB, et al. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera®) as a contraceptive agent. Acta Endocrinol. 1982;99:339–343. doi:10.1530/acta.0.0990339.
  • Onderdonk AB, Delaney ML, Fichorova RN. The human microbiome during bacterial vaginosis. Clin Microbiol Rev. 2016;29:223–238. doi:10.1128/CMR.00075-15.
  • Mishell Jr DR. Pharmacokinetics of depot medroxyprogesterone acetate contraception. J Reprod Med. 1996;41:381–390.
  • Bauer E, Thiele I. From network analysis to functional metabolic modeling of the human gut microbiota. mSystems. 2018;3; doi:10.1128/mSystems.00209-17.
  • Yang L, Poles MA, Fisch GS, et al. HIV-induced immunosuppression is associated with colonization of the proximal gut by environmental bacteria. AIDS. 2016;30:19–29.
  • Ren W, Ma Y, Yang L, et al. Fast disease progression in simian HIV-infected female macaque is accompanied by a robust local inflammatory innate immune and microbial response. AIDS. 2015;29:F1–F8. doi:10.1097/QAD.0000000000000711.
  • Ñahui Palomino RA, Zicari S, Vanpouille C, et al. Vaginal lactobacillus inhibits HIV-1 replication in human tissues ex vivo. Front Microbiol. 2017;8:906. doi:10.3389/fmicb.2017.00906.
  • Gosmann C, Anahtar MN, Handley SA, et al. Lactobacillus-deficient cervicovaginal bacterial communities are associated with increased HIV acquisition in young South African women. Immunity. 2017;46:29–37. doi:10.1016/j.immuni.2016.12.013.
  • Kaul R, Pettengell C, Sheth PM, et al. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission. J Reprod Immunol. 2008;77:32–40. doi:10.1016/j.jri.2007.02.002.
  • Thurman AR, Doncel GF. Innate immunity and inflammatory response to Trichomonas vaginalis and bacterial vaginosis: relationship to HIV acquisition. Am J Reprod Immunol. 2011;65:89–98. doi:10.1111/j.1600-0897.2010.00902.x.
  • St John E, Mares D, Spear GT. Bacterial vaginosis and host immunity. Curr HIV/AIDS Rep. 2007;4:22–28. doi:10.1007/s11904-007-0004-y.
  • Macaluso M, Lawson L, Akers R, et al. Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure. Contraception. 1999;59:195–201. doi:10.1016/S0010-7824(99)00013-X.
  • Mauck CK, Doncel GF, Biomarkers of Semen Exposure Clinical Working Group. Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV. Contraception. 2007;75:407–419. doi: 10.1016/j.contraception.2007.02.007
  • Kulczycki A, Brill I, Snead MC, et al. Prostate-specific antigen concentration in vaginal fluid after exposure to semen. Contraception. 2017;96:336–343. doi:10.1016/j.contraception.2017.07.004.
  • Yang L, Lu X, Nossa CW, et al. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology. 2009;137:588–597. doi:10.1053/j.gastro.2009.04.046.
  • Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335–336. doi:10.1038/nmeth.f.303.
  • Lozupone C, Hamady M, Knight R. UniFrac - An online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics. 2006;7:371. doi:10.1186/1471-2105-7-371.
  • Zhao N, Chen J, Carroll I, et al. Testing in microbiome-profiling studies with MiRKAT, the microbiome regression-based kernel association test. Am J Hum Genet. 2015;96:797–807. doi:10.1016/j.ajhg.2015.04.003.
  • Benjamini Y, Hochberg Y. Controlling the false discovery rate – a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol. 1995;57:289–300. doi:10.1111/j.2517-6161.1995.tb02031.x.
  • Sadanandam A, Lyssiotis CA, Homicsko K, et al. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat Med. 2013;19:619–625. doi:10.1038/nm.3175.
  • Chen S, Sanjana NE, Zheng K, et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell. 2015;160:1246–1260. doi:10.1016/j.cell.2015.02.038.
  • Zhang X, Zhang D, Jia H, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015;21:895–905. doi:10.1038/nm.3914.
  • Armitage P. Tests for Linear Trends in Proportions and Frequencies. Biometrics. 1955;11:375–386. doi: 10.2307/3001775
  • Barberán A, Bates ST, Casamayor EO, et al. Using network analysis to explore co-occurrence patterns in soil microbial communities. ISME J. 2012;6:343–351. doi:10.1038/ismej.2011.119.
  • van Bruggen AHC, Semenov AM. In search of biological indicators for soil health and disease suppression. Appl Soil Ecol. 2000;15:13–24. doi:10.1016/S0929-1393(00)00068-8.
  • Wei T, Simko V. Corrplot: visualization of a correlation matrix; 2016.
  • Csardi G, Nepusz T. The igraph software package for complex network research. Int J Complex Syst. 2006;1695:1–9.
  • Harrell Jr, FE. Hmisc: Harrell Miscellaneous. https://CRAN.R-project.org/package=Hmisc 2008.
  • Bastian M, Heymann S, Jacomy M. Gephi: an open source software for exploring and manipulating networks. ICWSM. 2009;8:361–362.